S22-2 Measures for Promoting Early-Stage Exploratory Clinical Studies and Preventing Japanese Clinical Trials' Hollowing Out --From the View Point of Pharma Industries--
Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.42.85
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2011
Authors
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics